JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2015. Vol. 60. No. 2. P. 5-8
RADIATION BIOLOGY
K.V. Kotenko, B.B. Moroz, Yu.B. Deshevoy, T.A. Nasonova, O.A. Dobrynina, V.G. Lebedev, A.V. Lirshikova, I.I. Eremin
Syngenic Multipotent Mesenchymal Stromal Cells in the Treatment of Persisted Radiation Skin Ulcers in the Experiment
A.I. Burnasyan Federal Medical Biophysical Center of FMBA, Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: The effectiveness of syngenic multipotent mesenchymal stromal cells (MMSC) in treatment of persisted radiation skin ulcers caused by relatively soft x-ray was studied.
Material and methods: Experiments were carried out on rats by the inbreed strain Wistar-Kyoto. Rats had been irradiated locally in lumbar-iliac region using x-ray machine RAP 100-110 with the dose of 110 Gy (30 kV tube voltage, current 6.1 ma, thick Al filter 0.1 mm). Dose rate is 173 Gy/min. 27 rats (from 40 being irradiated) with expanded radiation skin ulcers of the were selected on day 84 after exposure to radiation. This group of animals were divided into three groups (in accordance with the dimensions and clinical course of ulcers) Two groups of rats have been treated with transplantation of MMSC isolated from bone marrow and developed in vitro: once (in 85 days) or twice(on 85 and 93 days). MMSC (1.7×106 cells per injection) was injected under the skin around the radiation ulcer. The third group was the control.
Results: The double imposition of syngenic MMSC stimulated healing of persisted radiation ulcers, that became clear from 93 to 111 days after exposure.
Conclusion: The findings suggest that singenic MMSC can be effective in the treatment of persisted radiation skin ulcers.
Key words: multipotent mesenchymal stromal cells, X-ray, radiation skin ulcers
REFERENCES
- Radiatsionnaya meditsina. Rukovodstvo dlya vrachei-issledovatelei i organizatorov zdravookhraneniya. In L.A. Il'ina (ed.). Moscow: Publ. AT. 2001. Vol. 2. 432 p. (In Russ.).
- Bushmanov A.Yu., Nadezhina N.M., Nugis V.Yu., Galstyan I.A. Mestnye luchevye porazheniya kozhi cheloveka: vozmozhnosti biologicheskoi indikatsii dozy (analiticheskii obzor). Medical Radiology and Radiation Safety. 2005. Vol. 50. No. 1. P. 37-47. (In Russ.).
- Selidovkin G.D. Meditsinskaya pomoshch' pri radiatsionnoi avarii s istochnikom tseziya-137 v Brazilii (1987). V kn. «Meditsinskie aspekty avarii na Chernobyl'skoi atomnoi stantsii». Kiev: Zdorov'e. 1988. P. 180-185. (In Russ.).
- Moroz B.B., Onishchenko N.A., Lebedev V.G. et. al. Vliyanie mul'tipotentnykh mezenkhimal'nykh stromal'nykh kletok kostnogo mozga na techenie mestnykh luchevykh porazhenii u krys posle lokal'nogo β-oblucheniya. Radiats. biologiya. Radioekologiya. 2009. Vol. 49. No. 6. P. 688-693. (In Russ.).
- Kotenko K.V., Moroz B.B., Nadezhina N.M. et. al. Transplantatsiya mezenkhimal'nykh kletok pri lechenii luchevykh porazhenii kozhi. Patol. fiziologiya i eksper. terapiya. 2011. No. 1. P. 2-7. (In Russ.).
- Kotenko K.V., Eremin I.I., Moroz B.B. et. al. Kletochnye tekhnologii v lechenii radiatsionnykh ozhogov: opyt FMBTs im. A.I. Burnazyana. Kletochnaya transplantologiya i tkanevaya inzheneriya. 2012. Vol. 7. No. 2. P. 97-102. (In Russ.).
- Kotenko K.V., Moroz B.B., Nasonova T.A. et. al. Eksperimental'naya model' tyazhelykh mestnykh luchevykh porazhenii kozhi posle deistviya rentgenovskogo izlucheniya. Patol. fiziologiya i eksper. terapiya. 2011. No. 4. P. 121-123. (In Russ.).
- Chertkov I.L., Gurevich O.A. Stvolovaya krovetvornaya kletka i ee mikrookruzhenie. Moscow: Meditsina. 1984. 238 p. (In Russ.).
- Clark R.A.F., Nielsen L.D., Welch M.P., McPherson J. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-b. J. Cell. Sci. 1995. Vol. 108. P. 1251-1261.
- Klein G. The extracellular matrix of the hematopoietic microenvironment. Experientia. 1995. Vol. 51. P. 914-926.
- Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997. Vol. 276. P. 71-74.
- Pittenger M.F., Mackay A.M., Beck S.C. et al. Multilineage potential of adult human mesenchymal stem cells. Science.1999. Vol. 284. No. 2. P. 143-147.
- Reese J.S., Koc O.N., Geson S.L. Human mesenchymal stem cells provide stromal support for efficient CD 34+ transduction. J. Hematother. Stem Cell Res., 1999. Vol. 8. P. 515-523.
- Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell Physiol. 1999. Vol. 181. P. 67-73.
- Cheng L., Qasba P., Vanguri P. et al. Human mesenchymal stem cells support megakaryocyte and proplatelet formation from CD 34+ hematopoietic progenitor cells. J. Cell Physiol. 2000. Vol. 184. P. 58-69.
- Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp. Biol. Med. 2001. Vol. 226. No. 6. P. 507-520.
For citation: Kotenko KV, Moroz BB, Deshevoy Yu.B, Nasonova TA, Dobrynina OA, Lebedev VG, Lirshikova AV, Eremin II. Syngenic Multipotent Mesenchymal Stromal Cells in the Treatment of Persisted Radiation Skin Ulcers in the Experiment. Medical Radiology and Radiation Safety. 2015;60(2):5-8. Russian.
PDF (RUS) Full-text article (in Russian)